Trial
NCT03180762
A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy Participants
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Healthy
Intervention
JNJ-64140284 0.1 mg
Why stopped
Trial stopped: A SAE has occured. As a measure of precaution, the trial has been stopped.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-30